Total public drug program spending in Canada by therapy 2019

This statistic displays the total public drug program expenditure in Canada by broad therapeutic category in 2019. In that year, total drug program spending dedicated to antineoplastic and immunomodulating agents totaled some 3.44 billion Canadian dollars.

Total public drug program spending in Canada by therapy in 2019* (in million Canadian dollars)

Characteristic	Spending in million Canadian dollars
Antineoplastic and immunomodulating agents	3,434.7
Nervous system	2,260.5
Alimentary tract and metabolism	2,013.8
Cardiovascular system	1,433.6
Anti-infectives for systemic use	1,172.4
Sensory organs	960.2
Respiratory system	895.4
Blood and blood-forming organs	808
Musculoskeletal system	419.8
Genitourinary system and sex hormones	337.1
Systemic hormonal preparations	248.9
Dermatologicals	150.3
Various	139.8
Anti-parasitic products, insecticides and repellents	24.1
Unassigned**	201.5
Non-drug products***	478.8

Loading statistic...

Download

Source

Show detailed source information?

Already a member?

Source

Use Ask Statista Research Service

Release date

December 2020

More information

Region

Canada

Survey time period

2019

Supplementary notes

* Currently, the Northwest Territories and Nunavut do not submit data to NPDUIS.
** This category includes products without an assigned Anatomical Therapeutic Chemical (ATC) code.
*** Non-drug products include, but are not limited to, diabetic supplies, wound care, ostomy supplies and pharmaceutical services.

Open this statistic in...

Spanish